Danaher Stock: Is Wall Street Bullish or Bearish?

Washington, D.C.-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical, industrial, and commercial products and services. With a market cap of $201.2 billion, Danaher operates through the Biotechnology, Diagnostics, and Life Sciences segments.

Shares of the diagnostics & research giant have struggled to keep pace with the broader market over the past year. Over the past 52 weeks, DHR gained 22.2% compared to the S&P 500 Index’s ($SPX) 27.8% returns. In 2024, DHR is up 17.2%, while SPX returned 17.8% on a YTD basis.